AG0008BR

102767-28-2 | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide

Chemical structure of (2S)-2-(2-oxopyrrolidin-1-yl)butanamide, CAS 102767-28-2
AG0008BR
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 102767-28-2
Catalog Number AG0008BR(AGN-PC-0ORTKZ)
Chemical Name (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
EC Number 600-348-9
IUPAC Name (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
InChI InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChI Key HPHUVLMMVZITSG-LURJTMIESA-N
MDL Number MFCD03265610
Molecular Formula C8H14N2O2
Molecular Weight 170.2090
NSC Number 760119
SMILES O=C1N(CCC1)[C@H](C(=O)N)CC
UNII 44YRR34555
Synonyms
alpha ethyl 2 oxo 1 Pyrrolidineacetamide, alpha-ethyl-2-oxo-1-pyrrolidineacetamide, etiracetam, Etiracetam, (R)-, Etiracetam, R isomer, etiracetam, R-isomer, Etiracetam, S isomer, etiracetam, S-isomer, Keppra, levetiracetam, R-isomer Etiracetam, S-isomer Etiracetam, UCB 6474, ucb L059, ucb L060, UCB-6474, ucb-L059, ucb-L060, UCB6474, UcbL060, Levetiracetam, 102767-28-2, Keppra, (S)-2-(2-Oxopyrrolidin-1-yl)butanamide, Keppra XR, ucb L059, Levetiracetamum, UCB-L 059, (2S)-2-(2-oxopyrrolidin-1-yl)butanamide, UCB-L059, Spritam, (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, SIB-S1, (-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, UNII-44YRR34555, 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-, MFCD03265610, UCB-22059, Levetiracetamum [INN-Latin], Levetiractam, CHEBI:6437, ucb L060, Levetiracetam In Sodium Chloride, 44YRR34555, Levroxa, (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (S)-, (S)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE, etiracetam, S-isomer, matever, Leviteracetam, Levipil, Torleva, Elepsia XR, (S)-Levetiracetam, SMR000466303, Keppra (TN), Levesam 500, Etiracetam levo-isomer, SR-01000759400, Levetiracetame, E Keppra, HSDB 7528, Keppra;Keppra XR, Levetiracetam [USAN:USP:INN:BAN], E keppra (TN), (S)-2-(2-Oxo-1-pyrrolidinyl)butyramide, AC1NR4PY, L-059, 2(S)-(2-OXOPYRROLIDIN-1-YL)BUTYRAMIDE, CHEMBL1286, MLS000759403, MLS001424069, MLS006010215, BIDD:GT0242, SCHEMBL118843, GTPL6826, DTXSID9023207, Levetiracetam (JAN/USAN/INN), CTK3J2270, KS-00000ILW, HPHUVLMMVZITSG-LURJTMIESA-N, Levetiracetam, >=98% (HPLC), Levetiracetam, analytical standard, HMS2051D07, HMS2089L20, HMS2235I18, HMS3262H11, HMS3713P16, Pharmakon1600-01502265, ACT02712, ALBB-027275, BCP11856, HY-B0106, ZINC1547851, Tox21_500835, ANW-41693, BDBM50422542, NSC760119, s1356, STL388027, UCB 22059, Levetiracetam 1.0 mg/ml in Methanol, AKOS015841981, AB13957, AC-1479, CCG-100928, CS-1854, DB01202, KS-1176, LP00835, LS41261, MCULE-5120797917, NC00178, NSC-760119, RP23251, RTC-063977, (2S)-(2-Oxopyrrolidin-1-yl)butyramide, NCGC00186028-01, NCGC00261520-01, (S)-2-(2-oxopyrrolidin-1-yl)butyramide, AJ-26885, BC208262, BR-72955, CJ-24357, CPD000466303, SAM001246539, SC-15831, (s)-2-(2-oxopyrrolidin-1-yl) butyramide, (2S)-2-(2-oxo-1-pyrrolidinyl)butanamide, AB0012613, AB2000064, LS-137054, ST2408279, TL8000131, AM20070676, FT-0082600, FT-0602577, L0234, SW197558-3, C07841, D00709, M-2814, AB00639945-06, AB00639945_07, AB00639945_08, 767L282, A800616, (?S)?-?-?Ethyl-?2-?oxo-1-?pyrrolidineacetamide, (2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide, Q-201292, SR-01000759400-4, SR-01000759400-5, (ALPHAS)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE, UNII-230447L0GL component HPHUVLMMVZITSG-LURJTMIESA-N, Levetiracetam, European Pharmacopoeia (EP) Reference Standard, Levetiracetam, United States Pharmacopeia (USP) Reference Standard, Levetiracetam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Levitiracetam, Pharmaceutical Secondary Standard; Certified Reference Material, Etiracetam, Levetriacetam, Levetiracetam [INN], R-isomer Etiracetam, S-isomer Etiracetam, (-)-Levetiracetam, Etiracetam, (R)-, etiracetam, R-isomer, Etiracetam, R isomer, Etiracetam, S isomer, ucb-L060, UcbL060, D01XRM, D0E1XL, C8H14N2O2, UCB 6474, UCB-6474, Levetiracetam, 98% - 1g 1g, UCB6474, Keppra, Keppra XR),Levetiracetam, C8-H14-N2-O2, CID5284583, alpha ethyl 2 oxo 1 Pyrrolidineacetamide, alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, A1198, (alpha S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, D000077287, Levetiracetam; (S)-2-(2-oxopyrrolidin-1-yl)butanamide, 114915-28-5,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited